Michael W. Dunne

Overview

Michael W. Dunne received an average of $877K in total compensation, including $383K in salary, at Iterum Therapeutics plc from 2017 to 2019.

Source: SEC filings on May 7, 2020 and April 25, 2019.

Related executives

We found three more executives who work or worked at Iterum Therapeutics plc.

Corey Fishman

Iterum Therapeutics plc

Chief Executive Officer

Judith Matthews

Iterum Therapeutics plc

Chief Financial Officer

Sailaja Puttagunta

Iterum Therapeutics plc

Chief Medical Officer

News

You may also like